Polycystic Ovarian Syndrome Market Insights, Growth Outlook, Segmentation and Investment | Forecast to 2027
Polycystic Ovarian Syndrome Market Highlights
The Polycystic ovarian syndrome market is
expected to witness tremendous growth owing to the rising prevalence of
polycystic ovarian syndrome. Other key factors such as the growing obesity
among women, increase in hormonal disorders in women, change in sedentary
lifestyle, socioeconomic factors, growing consumption of unhealthy diet,
increasing occurrence of diabetes in women, and others are contributing towards
the growth of the market. However, factors such as high cost of diagnostic
procedures, expensive treatments, and side effects associated with drugs are
expected to hinder the market growth during the forecast period.
Segmentation
The
global polycystic ovarian syndrome market is segmented on the basis of
diagnosis, treatment, and end-user. The polycystic ovarian syndrome market, by
diagnosis, is categorized into pelvic examination, transvaginal ultrasound, and
blood tests. Blood tests are further sub-segmented into hormone levels, glucose
tolerance, and cholesterol and triglyceride levels. On the basis of treatment,
the market is segmented into oral contraceptives, antiandrogens,
insulin-sensitizing agents, antidepressant, anti-obesity, and surgery. The
surgery category includes ovarian wedge resection and laparoscopic ovarian
drilling. On the basis of end-user, the market is segmented into hospitals and
clinics, ambulatory surgical centers, diagnostic centers, gynecology centers,
feminist health centers, and others.
Request
Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/6295
Regional Analysis
The
Americas is expected to dominate the polycystic ovarian syndrome market during
the forecast period. The increasing prevalence of polycystic ovarian syndrome
drives the market in this region. According to the Centers for Disease Control
and Prevention, the Polycystic Ovary Syndrome (PCOS) affects 6 to 12% of the
American women of the childbearing age. This is expected to influence the
market growth during the forecast period.
Europe
(UK, Belgium, France, and Netherlands) is the second largest in the market
owing to the increasing prevalence of obesity and growing healthcare
expenditure. The increasing research activities for Polycystic Ovary Syndrome
(PCOS) are influencing the market growth.
EuroSciCon will hold the 5th World Congress on Polycystic Ovarian
Disorder in April 2019 in Berlin, Germany to discuss diagnosis and intervention
of the polycystic ovarian syndrome.
Asia-Pacific
was projected to be the fastest growing region for the global polycystic
ovarian syndrome market in 2017. The market is expected to witness growth owing
to the rising prevalence of diabetes in women, changing lifestyle, and growing
obesity within the female population. The Asian Diabetes Prevention Initiative
estimated that by 2030 India and China will have a diabetic patient pool with a
total of half billion people. Furthermore, according to the Journal of the
American Medical Association in 2013, China had 187.7 million women suffering
from prediabetes. This is expected to provide favorable backgrounds for the
market to grow.
The
Middle East and Africa accounts for the least share due to stringent government
policies and low per capita income.
Key Players
Some of
the key players in the global polycystic ovarian syndrome market are Bayer AG,
AstraZeneca plc, Abbott, Biocinese, Catalysis, S.L., Crinetics Pharmaceuticals,
Inc., Sanofi, Eugonia, EffRx, Inc., Ferring Pharmaceuticals, Inc., Merck KGaA,
Bristol-Myer Squibb Company, Neurocrine Biosciences, Inc., Reliance Life
Sciences Pvt. Ltd. Pfizer, Inc., Novartis AG, and Shire Plc.
Browse Detailed TOC with
COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/polycystic-ovarian-syndrome-market-6295
About
Market Research Future:
At Market Research Future
(MRFR), we enable our customers to unravel the complexity of various industries
through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
& Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email:
sales@marketresearchfuture.com
Comments
Post a Comment